Genistein
The isolated soy isoflavone with the most bone data behind it. Effects on bone density are consistent but small, and menopausal symptom relief is real but modest.
Evidence last reviewed: August 2026
What the science says
- Bone mineral density Moderate evidence
A follow-up of a randomized trial of genistein aglycone in postmenopausal women with bone loss reported increases in bone mineral density over three years without adverse breast effects, and a systematic review and meta-analysis of isoflavone trials found a small overall benefit for bone mineral density.
- Menopausal symptoms Moderate evidence
A multi-center randomized placebo-controlled trial of synthetic genistein in healthy postmenopausal women reported reduced hot flash frequency. The size of the effect is smaller than with hormone therapy.
Dosage & safety
Scientific references
- Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
- Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials
- The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study
Where to buy
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Women's health
- Folic Acid (Vitamin B9) Strong evidence
- Inositol (Myo-Inositol) Moderate evidence
- Strontium Limited evidence
- Soy Isoflavones Moderate evidence
- Ipriflavone Limited evidence
- Evening Primrose Oil Limited evidence